Navigation Links
Yongye Biotechnology Announces Record Third Quarter Results
Date:11/13/2008

es network of stores. An additional 575 branded stores were added to the network in the first half of 2008, bringing the total number of stores through which the Company distributed its products in the third quarter to 775. The expanded sales network resulted in a total volume of 182,009 units sold of both plant and animal products in the third quarter of 2008, a 427.6% increase from 34,496 units sold in the third quarter of 2007. The Company's plant nutrient product accounted for 99.9% of sales revenue in the third quarter of 2008.

Gross profit was $8.9 million in the third quarter of 2008, a 456.6% increase from $1.6 million in the third quarter of 2007. Gross margin was 49.0% compared to 61.1% in the third quarter of 2007. Margin declined mostly because of discounts being given to key distributors and the cost of production being higher in 2008 compared to 2007.

Selling, General and Administrative expenses were $3.9 million in the third quarter of 2008, compared to $355,784 in the third quarter of 2007. These expenses as a percentage of sales increased because of expanded advertising, adding new management personnel, and freight costs of $3,408,813 compared to $140,205 in the third quarter of 2007, an increase of $3,268,608, or 2,331%. Freight costs increased dramatically because the Company distributed products to ten provinces in the third quarter of 2008 compared to four provinces in the third quarter of 2007. The predecessor company that existed in 2007 that became Yongye had a cost structure that was similar to Yongye's current cost structure, but on a much smaller scale.

Income from Operations was $5.0 million in the third quarter of 2008, with operating margin of 27.6%, compared to $1.2 million during the third quarter of 2007, with operating margin 47.5%.

Net income grew 283.5% to $4.5 million in the third quarter of 2008, or $0.22 per diluted share, compared to net income of $1.2 million, or $0.10 per diluted share, in the thi
'/>"/>

SOURCE Yongye Biotechnology International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Yongye Biotechnology to Present at Roth Capital China Comes to Vegas Conference
2. Letter to Shareholders from the CEO and Chairman of the Board of Yongye Biotechnology, Inc.
3. Yongye Biotechnology International Raises $9.4 Million in Private Placement
4. Yongye Biotechnology International Announces Second Quarter Results
5. Yongye Biotechnology International Announces Conference Call to Discuss Second Quarter 2008 Results
6. Yongye Biotechnology International Retains CCG Investor Relations
7. Yongye Biotechnology International, Inc. Appoints New Independent Auditor
8. Yongye Biotechnology Completes Reverse Merger and Completes $10.0 Million Private Financing
9. World Market for Biotechnology Reagents to Reach $32.5 Billion by 2012, According to New Report by Global Industry Analysts, Inc.
10. InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
11. InNexus Biotechnology Receives Patent Grants in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015 In response ... FedEx, UPS and The US Postal Service to ... classified as ,select agents, by the CDC, Marken ... handling these sensitive shipments. Marken uses ... regulations, trained and certified personnel to ensure the ...
(Date:8/26/2015)... 26, 2015  Roka Bioscience, Inc. (NASDAQ: ROKA ... testing solutions for the detection of foodborne pathogens, today ... the Sidoti & Company Emerging Growth Conference on September ... at the New York Marriott Marquis. ... through the investor relations section of Roka Bioscience,s website ...
(Date:8/26/2015)... GERMANTOWN, Md. , Aug. 26, 2015 ... synthetic biology, announced today the closing of its previously ... in full by the underwriters of their option to ... the public offering price of $41.00 per share.  The ... of shares of common stock sold by Intrexon to ...
(Date:8/26/2015)... , August 26, 2015 ... biggest factors fueling the optimism in biotech,s forecast ... collaborations and life sciences advancements.  Active biotechnology & ... Pressure BioSciences, Inc. (OTCQB: PBIO), Sequenom, Inc. (NASDAQ: ... SRPT ), Raptor Pharmaceutical Corp. (NASDAQ: RPTP ...
Breaking Biology Technology:Marken Ensures Safe Transportation Of Select Agents And Toxins 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 2Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 3Intrexon Announces Closing of $230 Million Public Offering of Common Stock including Full Exercise of Underwriters' Option to Purchase Additional Shares 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 2New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 3New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 4New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 5New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 6New Collaborations & Mergers For Research of Molecular Biomarkers in Human Diseases & Clinical Trials for Cancer Therapies Fueling Growth in Multi-Billion Dollar Life Sciences Market 7
... Plans to Continue Efforts to Out-License Intellectual ... ... Interleukin Genetics,Inc. (Amex: ILI ), and Access Business Group ... will increase access to all,intellectual property related to genetic tests jointly ...
... Sept. 4 SAFC Hitech(TM), a focus,area within ... SIAL ),today announced that it has made ... GST) precursors for use in,high volume manufacturing phase ... conducted with both the precursors and with the,use ...
... - Therapure Biopharma Inc., a Canadian,biopharmaceutical company, ... and has,its first contracts with customers in ... Ontario, just 30 minutes from Toronto,s Pearson,International ... for the development and manufacture of complex ...
Cached Biology Technology:Interleukin Genetics and Alticor Agree on Expansion of Distribution Channels for Genetic Tests 2Interleukin Genetics and Alticor Agree on Expansion of Distribution Channels for Genetic Tests 3SAFC Hitech(TM) Successfully Demonstrates Device-Quality GST Precursors For Phase Change Memory Applications 2SAFC Hitech(TM) Successfully Demonstrates Device-Quality GST Precursors For Phase Change Memory Applications 3SAFC Hitech(TM) Successfully Demonstrates Device-Quality GST Precursors For Phase Change Memory Applications 4Therapure Biopharma Inc. opens for business with first client contracts 2
(Date:8/6/2015)... TELTOW, Germany , August 6, 2015 ... SensoMotoric Instruments (SMI) shows the world,s first ... based on Epson,s Moverio BT-200 see-through head mounted ... this new solution, unprecedented quality and efficiency is brought ... context-sensitive displays. For the first time, professionals and researchers ...
(Date:8/4/2015)... DUBLIN , Aug. 04, 2015 /PRNewswire/ ... ( http://www.researchandmarkets.com/research/nvh7k2/digital_forensics ) has announced the addition ... Component (Hardware, Software, and Service), Sub-Segment (Computer ... Cloud Forensics), Tool Types, Service, Vertical and ... report to their offering. By ...
(Date:7/31/2015)... , 31 de julho de 2015 A ... www.icg-10.org ) será realizada pela BGI de 22-25 de outubro ... A conferência está celebrando seu 10 o. ... a ICG se tornou uma das reuniões mais influentes ... encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
Breaking Biology News(10 mins):SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 2SMI Shows First Eye Tracking Upgrade for Augmented Reality Glasses 3Digital Forensics Market - The Market Represents a Compound Annual Growth Rate (CAGR) of 11.3% From 2015 to 2020 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
... type of prominent brain rhythm that orchestrates neuronal activity ... formation of new memories. For several decades these oscillations ... timing the firing of neurons like a sort of ... the California Institute of Technology (Caltech) argues that this ...
... Drug-facilitated sexual crimes are increasing. The Bonn Institute for ... on the use of intoxicants in sexual offences within ... In the current edition of Deutsches rzteblatt ... of action and the detection windows for the most ...
... devastating effects on endangered species, but new mathematical models ... of bighorn sheep. The effects of a changing ... mathematically predicted, as described in a recent paper recommended ... Lochran Traill. Researchers from Germany, the US, and ...
Cached Biology News:Caltech scientists reveal how neuronal activity is timed in brain's memory-making circuits 2Caltech scientists reveal how neuronal activity is timed in brain's memory-making circuits 3
HP 1 alpha Immunogen: Synthetic peptide between amino acids 1-100 of the human HP 1 alpha protein. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... Custom Synthesis Service provides you ... to knockdown any gene. We ... base pairs with terminal dT ... other lengths of your choice. ...
Tracker Datamatrix RS-1* reads 96 2D Bar-coded tubes within 20 seconds....
Request Info...
Biology Products: